Glaukos Quarterly Balance Sheet

NYSE: GKOSHealth CareMedical/Dental InstrumentsUSD

165.69+4.40 (+2.73%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Glaukos financial position

As of Jun 30, 2026, Glaukos reported total assets of $920.5 million, down 6.7% from a year earlier against total liabilities of $238.0 million. Shareholders' equity stood at $682.5 million, or 74.1% of assets. The company held $114.5 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 5.04, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Glaukos balance sheet (quarterly)

Glaukos quarterly balance sheet
Quarter (USD)	Q2 20262026-06-30	Q1 20262026-03-31	Q4 20252025-12-31	Q3 20252025-09-30	Q2 20252025-06-30	Q1 20252025-03-31	Q4 20242024-12-31	Q3 20242024-09-30	Q2 20242024-06-30	Q1 20242024-03-31	Q4 20232023-12-31	Q3 20232023-09-30
Cash & Equivalents	114.48M	104.25M	90.81M	98.25M	100.81M	114.25M	169.63M	100.14M	68.08M	42.49M	93.47M	108.93M
Receivables	138.90M	119.69M	108.61M	98.68M	82.98M	71.53M	60.74M	56.41M	51.22M	46.55M	39.85M	39.33M
Inventory	59.31M	62.38M	63.56M	63.86M	64.62M	59.46M	57.68M	59.90M	56.48M	50.19M	41.99M	39.78M
Total Current Assets	515.78M	485.75M	474.98M	454.77M	436.06M	444.54M	449.79M	397.28M	383.78M	388.61M	395.46M	399.53M
Property, Plant & Equipment	112.11M	112.43M	113.25M	110.94M	111.82M	96.81M	97.87M	98.58M	100.23M	101.86M	103.21M	103.08M
Goodwill	66.71M	66.71M	66.71M	66.71M	66.71M	66.13M	66.13M	66.13M	66.13M	66.13M	66.13M	66.13M
Intangible Assets	127.15M	133.03M	141.92M	264.14M	270.49M	257.87M	263.44M	269.42M	275.67M	281.92M	282.96M	289.18M
Total Assets	920.52M	893.33M	893.49M	999.38M	986.96M	966.18M	974.76M	926.54M	919.67M	933.34M	940.41M	948.63M
Accounts Payable	19.14M	19.15M	24.62M	19.88M	13.68M	15.82M	13.03M	11.10M	11.56M	12.75M	13.44M	10.41M
Total Current Liabilities	102.33M	89.42M	101.28M	87.52M	79.14M	68.53M	75.13M	71.68M	70.08M	72.24M	74.01M	67.15M
Total Liabilities	238.03M	222.40M	237.33M	229.84M	221.85M	202.22M	207.82M	258.03M	254.52M	482.61M	478.65M	470.98M
Shareholders' Equity	682.49M	670.93M	656.15M	769.54M	765.11M	763.96M	766.93M	668.51M	665.16M	450.73M	461.77M	477.66M
Retained Earnings	-971.29M	-952.91M	-933.13M	-799.47M	-783.24M	-763.59M	-745.44M	-711.86M	-690.45M	-639.90M	-599.07M	-562.29M
Net Cash (Debt)	114.48M	104.25M	90.81M	98.25M	100.81M	114.25M	169.63M	100.14M	68.08M	42.49M	93.47M	108.93M
Shares Outstanding	58.86M	58.36M	57.51M	57.39M	57.25M	56.74M	56.44M	55.09M	54.82M	49.85M	49.12M	48.72M

This table shows 12 quarterly periods of Glaukos's balance sheet, from Q2 2026 back to Q3 2023, across 18 line items including cash & equivalents, receivables, inventory. Values in USD; B = billions, M = millions. Fiscal periods follow GKOS's reporting calendar. What is a balance sheet?